RAF1 and neoplasm: The expected mechanism-based increase in HSP72 expression [37,38] was observed in all 3 treated tumours, and a decrease in the expression of NEU/HER2, C-RAF and CDK4 was seen in 2 out of 3 tumours (Figure 2).